OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000UK20AB8

Delayed Deutsche Boerse AG 08:29:00 13/06/2024 BST
1.34 EUR -1.47% Intraday chart for OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE
Current month+5.43%
1 month+1.49%
Date Price Change
13/06/24 1.34 -1.47%
12/06/24 1.36 +5.43%
11/06/24 1.29 -0.77%
10/06/24 1.3 -4.41%
07/06/24 1.36 +3.82%

Delayed Quote Deutsche Boerse AG

Last update June 13, 2024 at 08:29 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer UBS
WKN UK20AB
ISINDE000UK20AB8
Date issued 21/06/2022
Strike 26.43
Maturity Unlimited
Parity 10 : 1
Emission price 2.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.58
Lowest since issue 0.14
Spread 0.01
Spread %0.74%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.05 EUR
Average target price
39.97 EUR
Spread / Average Target
-0.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW